Literature DB >> 31268217

Functional and cellular localization diversity associated with Fukutin-related protein patient genetic variants.

Sara F Henriques1, Evelyne Gicquel1, Justine Marsolier1, Isabelle Richard1.   

Abstract

Genetic variants in Fukutin-related protein (FKRP), an essential enzyme of the glycosylation pathway of α-dystroglycan, can lead to pathologies with different severities affecting the eye, brain, and muscle tissues. Here, we generate an in vitro cellular system to characterize the cellular localization as well as the functional potential of the most common FKRP patient missense mutations. We observe a differential retention in the endoplasmic reticulum (ER), the indication of misfolded proteins. We find data supporting that mutant protein able to overcome this ER-retention through overexpression present functional levels comparable to the wild-type. We also identify a specific region in FKRP protein localized between residues 300 and 321 in which genetic variants found in patients lead to correctly localized proteins but which are nevertheless functionally impaired or catalytically dead in our model, indicating that this particular region might be important for the enzymatic activity of FKRP within the Golgi. Our system thus allows the functional testing of patient-specific mutant proteins and the identification of candidate mutants to be further explored with the aim of finding pharmacological treatments targeting the protein quality control system.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  FKRP; LGMD2I; dystroglycan; genetic variants; glycosylation; missense mutations; protein quality control

Mesh:

Substances:

Year:  2019        PMID: 31268217     DOI: 10.1002/humu.23827

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

Review 1.  Fukutin-Related Protein: From Pathology to Treatments.

Authors:  Carolina Ortiz-Cordero; Karim Azzag; Rita C R Perlingeiro
Journal:  Trends Cell Biol       Date:  2020-12-01       Impact factor: 20.808

2.  Defective autophagy and increased apoptosis contribute toward the pathogenesis of FKRP-associated muscular dystrophies.

Authors:  Carolina Ortiz-Cordero; Claudia Bincoletto; Neha R Dhoke; Sridhar Selvaraj; Alessandro Magli; Haowen Zhou; Do-Hyung Kim; Anne G Bang; Rita C R Perlingeiro
Journal:  Stem Cell Reports       Date:  2021-10-14       Impact factor: 7.765

3.  Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies.

Authors:  Celine Bruge; Marine Geoffroy; Manon Benabides; Emilie Pellier; Evelyne Gicquel; Jamila Dhiab; Lucile Hoch; Isabelle Richard; Xavier Nissan
Journal:  Biomedicines       Date:  2022-06-16

4.  Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy.

Authors:  Naoyuki Kuwabara; Rieko Imae; Hiroshi Manya; Tomohiro Tanaka; Mamoru Mizuno; Hiroki Tsumoto; Motoi Kanagawa; Kazuhiro Kobayashi; Tatsushi Toda; Toshiya Senda; Tamao Endo; Ryuichi Kato
Journal:  Nat Commun       Date:  2020-01-16       Impact factor: 14.919

5.  High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of α-dystroglycan.

Authors:  Maria Giulia Bigotti; Andrea Brancaccio
Journal:  Open Biol       Date:  2021-09-29       Impact factor: 6.411

6.  A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy.

Authors:  Neha R Dhoke; Hyunkee Kim; Sridhar Selvaraj; Karim Azzag; Haowen Zhou; Nelio A J Oliveira; Sudheer Tungtur; Carolina Ortiz-Cordero; James Kiley; Qi Long Lu; Anne G Bang; Rita C R Perlingeiro
Journal:  Cell Rep       Date:  2021-07-13       Impact factor: 9.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.